165 related articles for article (PubMed ID: 16938522)
1. Expression of Rsf-1, a chromatin-remodeling gene, in ovarian and breast carcinoma.
Mao TL; Hsu CY; Yen MJ; Gilks B; Sheu JJ; Gabrielson E; Vang R; Cope L; Kurman RJ; Wang TL; Shih IeM
Hum Pathol; 2006 Sep; 37(9):1169-75. PubMed ID: 16938522
[TBL] [Abstract][Full Text] [Related]
2. Amplification of a chromatin remodeling gene, Rsf-1/HBXAP, in ovarian carcinoma.
Shih IeM; Sheu JJ; Santillan A; Nakayama K; Yen MJ; Bristow RE; Vang R; Parmigiani G; Kurman RJ; Trope CG; Davidson B; Wang TL
Proc Natl Acad Sci U S A; 2005 Sep; 102(39):14004-9. PubMed ID: 16172393
[TBL] [Abstract][Full Text] [Related]
3. Rsf-1/HBXAP overexpression is independent of gene amplification and is associated with poor outcome in patients with urinary bladder urothelial carcinoma.
Liang PI; Wu LC; Sheu JJ; Wu TF; Shen KH; Wang YH; Wu WR; Shiue YL; Huang HY; Hsu HP; Chen YH; Chen LT; Li CF; Liao AC
J Clin Pathol; 2012 Sep; 65(9):802-7. PubMed ID: 22685262
[TBL] [Abstract][Full Text] [Related]
4. Expression of the chromatin remodeling factor Rsf-1 is down-regulated in breast carcinoma effusions.
Davidson B; Wang TL; Shih IeM; Berner A
Hum Pathol; 2008 Apr; 39(4):616-22. PubMed ID: 18289639
[TBL] [Abstract][Full Text] [Related]
5. Amplicon profiles in ovarian serous carcinomas.
Nakayama K; Nakayama N; Jinawath N; Salani R; Kurman RJ; Shih IeM; Wang TL
Int J Cancer; 2007 Jun; 120(12):2613-7. PubMed ID: 17351921
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of Rsf-1 correlates with pathological type, p53 status and survival in primary breast cancer.
Ren J; Chen QC; Jin F; Wu HZ; He M; Zhao L; Yu ZJ; Yao WF; Mi XY; Wang EH; Wei MJ
Int J Clin Exp Pathol; 2014; 7(9):5595-608. PubMed ID: 25337201
[TBL] [Abstract][Full Text] [Related]
7. Serous tubal intraepithelial carcinoma upregulates markers associated with high-grade serous carcinomas including Rsf-1 (HBXAP), cyclin E and fatty acid synthase.
Sehdev AS; Kurman RJ; Kuhn E; Shih IeM
Mod Pathol; 2010 Jun; 23(6):844-55. PubMed ID: 20228782
[TBL] [Abstract][Full Text] [Related]
8. Expression of the chromatin remodeling factor Rsf-1 is upregulated in ovarian carcinoma effusions and predicts poor survival.
Davidson B; Trope' CG; Wang TL; Shih IeM
Gynecol Oncol; 2006 Dec; 103(3):814-9. PubMed ID: 16844205
[TBL] [Abstract][Full Text] [Related]
9. Rsf-1, a chromatin remodelling protein, interacts with cyclin E1 and promotes tumour development.
Sheu JJ; Choi JH; Guan B; Tsai FJ; Hua CH; Lai MT; Wang TL; Shih IeM
J Pathol; 2013 Mar; 229(4):559-68. PubMed ID: 23378270
[TBL] [Abstract][Full Text] [Related]
10. [Clinicopathologic analysis and expression of cyclin D1 and p53 of ovarian borderline tumors and carcinomas].
Shao HL; Shen DH; Xue WC; Li Y; Yu YZ
Zhonghua Fu Chan Ke Za Zhi; 2007 Apr; 42(4):227-32. PubMed ID: 17631760
[TBL] [Abstract][Full Text] [Related]
11. Rsf-1 (HBXAP) expression is associated with advanced stage and lymph node metastasis in ovarian clear cell carcinoma.
Maeda D; Chen X; Guan B; Nakagawa S; Yano T; Taketani Y; Fukayama M; Wang TL; Shih IeM
Int J Gynecol Pathol; 2011 Jan; 30(1):30-5. PubMed ID: 21131837
[TBL] [Abstract][Full Text] [Related]
12. Pattern of HER-2 Gene Amplification and Protein Expression in Benign, Borderline, and Malignant Ovarian Serous and Mucinous Neoplasms.
Mohammed RAA; Makboul R; Elsers DAH; Elsaba TMAM; Thalab AMAB; Shaaban OM
Int J Gynecol Pathol; 2017 Jan; 36(1):50-57. PubMed ID: 27309616
[TBL] [Abstract][Full Text] [Related]
13. Functional analysis of 11q13.5 amplicon identifies Rsf-1 (HBXAP) as a gene involved in paclitaxel resistance in ovarian cancer.
Choi JH; Sheu JJ; Guan B; Jinawath N; Markowski P; Wang TL; Shih IeM
Cancer Res; 2009 Feb; 69(4):1407-15. PubMed ID: 19190325
[TBL] [Abstract][Full Text] [Related]
14. The gene copy number of c-MET has a significant impact on progression-free survival in Korean patients with ovarian carcinoma.
Kim WY; Shim SH; Jung HY; Dong M; Kim SN; Lee SJ
Hum Pathol; 2017 Jun; 64():98-105. PubMed ID: 28428108
[TBL] [Abstract][Full Text] [Related]
15. DNA Damage Response is Prominent in Ovarian High-Grade Serous Carcinomas, Especially Those with Rsf-1 (HBXAP) Overexpression.
Kshirsagar M; Jiang W; Shih IeM
J Oncol; 2012; 2012():621685. PubMed ID: 22028712
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of a chromatin remodeling factor, RSF-1/HBXAP, correlates with aggressive oral squamous cell carcinoma.
Fang FM; Li CF; Huang HY; Lai MT; Chen CM; Chiu IW; Wang TL; Tsai FJ; Shih IeM; Sheu JJ
Am J Pathol; 2011 May; 178(5):2407-15. PubMed ID: 21514451
[TBL] [Abstract][Full Text] [Related]
17. Her-2/neu expression and amplification in early stage ovarian surface epithelial neoplasms.
Wu Y; Soslow RA; Marshall DS; Leitao M; Chen B
Gynecol Oncol; 2004 Dec; 95(3):570-5. PubMed ID: 15581965
[TBL] [Abstract][Full Text] [Related]
18. Amplification of 11q13 in ovarian carcinoma.
Brown LA; Kalloger SE; Miller MA; Shih IeM; McKinney SE; Santos JL; Swenerton K; Spellman PT; Gray J; Gilks CB; Huntsman DG
Genes Chromosomes Cancer; 2008 Jun; 47(6):481-9. PubMed ID: 18314909
[TBL] [Abstract][Full Text] [Related]
19. Allelic analysis of serous ovarian carcinoma reveals two putative tumor suppressor loci at 18q22-q23 distal to SMAD4, SMAD2, and DCC.
Lassus H; Salovaara R; Aaltonen LA; Butzow R
Am J Pathol; 2001 Jul; 159(1):35-42. PubMed ID: 11438451
[TBL] [Abstract][Full Text] [Related]
20. Increased p16 expression in high-grade serous and undifferentiated carcinoma compared with other morphologic types of ovarian carcinoma.
Phillips V; Kelly P; McCluggage WG
Int J Gynecol Pathol; 2009 Mar; 28(2):179-86. PubMed ID: 19188815
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
